Therapeutic Advances in Drug Safety

SJR Rank #6,508H-index: 55SJR: 0.833Best quartile: Q2Open AccessAPC: US$2,800Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Pharmacology (medical)Q2

Areas: Medicine

Most published research topics

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical Practices and Patient OutcomesPatient Safety and Medication ErrorsMedication Adherence and CompliancePharmaceutical studies and practicesAtrial Fibrillation Management and OutcomesDrug-Induced Adverse ReactionsPharmaceutical Economics and PolicyDiabetes Treatment and ManagementBiosimilars and Bioanalytical Methods

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

20222025020406080

Detailed Information

ISSN

2042-0986, 2042-0994

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.96

References per Document

46.23

Coverage

2010-2026

Scope

Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Metrics from SCImago Journal Rank 2025. View on SCImago